Aucta has gained support from a dedicated group of investors including both global and China-based healthcare funds: Advantech, Cowin venture, Sangel, Grand Yangtze Capital, SDIC Venture Capital, etc..

Our investors are committed to support Aucta in becoming a significant specialty pharma player in both U.S. and China market place.